Antimicrobial Resistance of Helicobacter pylori Isolated From Latin American Children and Adolescents (2008-2023): A Systematic Review.
Camila CabreraJoaquín TorresCarolina A SerranoPaulina GallardoVicente OrellanaSergio A GeorgeMiguel O'RyanYalda LuceroPublished in: Helicobacter (2024)
Scarce Latin American studies on H. pylori resistance, along with methodological heterogeneity, hinder conclusive findings. Clarithromycin and metronidazole (first-line drugs) resistance is worrisome, likely impacting lower eradication rates. Urgent systematic surveillance or individual testing before treatment is necessary to enhance eradication.